Compare OGI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGI | RGC |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | Canada | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.5M | 8.4B |
| IPO Year | N/A | 2021 |
| Metric | OGI | RGC |
|---|---|---|
| Price | $2.04 | $18.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 217.0K |
| Earning Date | 12-16-2025 | 10-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $186,075,713.00 | N/A |
| Revenue This Year | $13.11 | N/A |
| Revenue Next Year | $12.47 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 62.15 | N/A |
| 52 Week Low | $0.85 | $0.09 |
| 52 Week High | $2.14 | $83.60 |
| Indicator | OGI | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 66.23 | 69.39 |
| Support Level | $1.49 | $16.30 |
| Resistance Level | $1.99 | $18.10 |
| Average True Range (ATR) | 0.14 | 1.70 |
| MACD | 0.05 | 0.45 |
| Stochastic Oscillator | 72.67 | 100.00 |
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.